.webp)
Agentic AI
Eliminate clinical trial white space with the right AI strategy
It has become clear that our industry has reachedthe limits of human-only clinical development. As clinical trials have become increasingly complex, the endeavors that people alone can perform are no longer sufficient to generate the momentum needed to address the growing burden of human disease. This has led to longer drug development timelines and significant delays for patients. One large are of lost time is “white space,” definied simply as unproductive time caused by manual, sequential processes and fragmented data systems. Thankfully, a solution lies in agentic AI and its abilities to perform series of tasks.
Back to basics: Agentic AI is Transforming trial design, management, and outcomes
Discover how Agentic AI is revolutionizing clinical trials by optimizing efficiency, accelerating drug development, and improving patient access to therapies.
An overview of Agent Studio
Agent Studio reimagines the clinical trial lifecycle, automating slow, manual processes, removing barriers in the clinical process, andintroducing new ways to achieve clinical goals like never before. This first-of-its-kind, AI-powered, no-code platform lets you deployready-to-go agents trained as clinical development experts or create bespoke ones using your own data and expertise, unlockingendless possibilities.
Rewriting the Future of Clinical Trials: AI, Agility, and the Portfolio-First Mandate
In a rapidly changing research landscape, leaders at Takeda, Novartis, Sanofi, Daiichi Sankyo, and Medable share firsthand insights into how artificial intelligence is reshaping clinical trial operations.
This exclusive whitepaper explores how forward-thinking organizations are reimagining trial design, execution, and scaling to meet the demands of speed, precision, and patient-centricity across their entire portfolio.